Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.015Source: DataRank Database

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report is a research paper published in Journal of Cystic Fibrosis (2025). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 12.39)OA: bronzeTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Dara Riva ORCID,Yair J. Blumenfeld ORCID,John F. Engelhardt ORCID,Carmen Luna‐Paredes,Carlos Milla ORCID

Live enrichment

PubMed:40754574 OpenAlex:https://openalex.org/W4412957225

National Institutes of Health

Grant: P30 DK 089,507

National Institutes of Health

Grant: UL1TR002319

National Health and Medical Research Council

Grant: 2024/ GNT2036793

National Heart, Lung, and Blood Institute

Grant: R01-HL171034

National Heart, Lung, and Blood Institute

Grant: GUIMBE23Y5

Cystic Fibrosis Foundation

Grant: TAYLOR19Y3

Cystic Fibrosis Foundation

Grant: MAYFLOWER-TAYLOR21A0

Cystic Fibrosis Foundation

Grant: JAIN21A0

NIDDK NIH HHS

Grant: P30 DK089507

NHLBI NIH HHS

Grant: R01 HL171034

State University of New York Upstate Medical University

National Jewish Health

Indiana University

Children's Hospital of Philadelphia

University of Melbourne

Johns Hopkins University

Oregon Health and Science University

Perelman School of Medicine, University of Pennsylvania

Stanford University

University of Iowa

FWCI

12.39

Citation Percentile

1.0%

Citation Trend

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttps://www.cysticfibrosisjournal.com/article/S1569-1993(25)01538-3/pdf

publisherhttps://www.cysticfibrosisjournal.com/article/S1569-1993(25)01538-3/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1569199325015383?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199325015383?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcf.2025.07.015

Fields of Study

Cystic Fibrosis Research AdvancesPregnancy and Medication ImpactNeonatal Respiratory Health ResearchHumansPregnancyFemaleCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorFetal TherapiesOff-Label Use

MeSH Terms

Cystic FibrosisFemaleHumansPregnancyCystic Fibrosis Transmembrane Conductance RegulatorFetal TherapiesOff-Label Use

Keywords

In uteroMedicineCystic fibrosisFetusPregnancyDosingIntensive care medicineCystic fibrosis transmembrane conductance regulatorPediatricsPharmacologyInternal medicineVas deferensPrenatalMeconium IleusCftr ModulatorVariant Specific Therapy

Sustainable Development Goals

SDG 0: Good health and well-being